Nuclotec Remedies Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
- Paid Up Capital ₹ 7.00 Cr
- Company Age 29 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.29 Cr
- Satisfied Charges ₹ 6.10 Cr
- Revenue Growth 13.09%
- Profit Growth -11.50%
- Ebitda 6.74%
- Net Worth -776.66%
- Total Assets -5.29%
About Nuclotec Remedies
Nuclotec Remedies Private Limited (NRPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 03 July 1995 and has a history of 29 years and nine months. Its registered office is in Delhi, India.
The Corporate was formerly known as Boats India Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 7.00 Cr.
The company currently has active open charges totaling ₹5.29 Cr. The company has closed loans amounting to ₹6.10 Cr, as per Ministry of Corporate Affairs (MCA) records.
Arun Anand and Kanika Anand serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74899DL1995PTC070408
- Company No.
070408
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Jul 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Pharma
Nuclotec Remedies Private Limited
Explore comprehensive data for Nuclotec Remedies Private Limited, including financials, compliance details, shareholding patterns, and litigation history.
Who are the key members and board of directors at Nuclotec Remedies?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arun Anand  | Director | 03-Jul-1995 | Current |
| Kanika Anand | Director | 01-Sep-2002 | Current |
Financial Performance of Nuclotec Remedies.
Nuclotec Remedies Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 13.09% increase. The company also saw a substantial fall in profitability, with a 11.5% decrease in profit. The company's net worth observed a substantial decline by a decrease of 776.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nuclotec Remedies?
In 2024, Nuclotec Remedies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
Open Charges
₹5.29 Cr
Satisfied Charges
₹6.10 Cr
Charges Breakdown by Lending Institutions
- Others : 4.95 Cr
- Axis Bank Limited : 0.34 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2023 | Axis Bank Limited | ₹3.37 M | Open |
| 29 Aug 2007 | Others | ₹4.95 Cr | Open |
| 23 Dec 2009 | Punjab National Bank | ₹1.60 Cr | Satisfied |
| 05 Nov 2008 | Punjab National Bank | ₹5.00 M | Satisfied |
| 29 Aug 2007 | Punjab National Bank | ₹3.70 Cr | Satisfied |
How Many Employees Work at Nuclotec Remedies?
Nuclotec Remedies has a workforce of 110 employees as of Mar 06, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nuclotec Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nuclotec Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Latest Updates, News, and FAQs on Nuclotec Remedies
Recent activity within the organization
- Charges
A charge registered on 19 Apr 2001 via Charge ID 80042907 with State Bank Of Patiala was fully satisfied on 17 Dec 2024.
- Annual General Meeting
Nuclotec Remedies Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.
- Balance Sheet
Nuclotec Remedies Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
- Charges
A charge with Axis Bank Limited amounted to Rs. 0.34 Cr with Charge ID 100724342 was registered on 25 Mar 2023.
- Charges
A charge registered on 05 Nov 2008 via Charge ID 10135685 with Punjab National Bank was fully satisfied on 28 Mar 2018.
- Charges
A charge registered on 29 Aug 2007 via Charge ID 10073645 with Punjab National Bank was fully satisfied on 28 Mar 2018.
Frequently asked questions
What is the Incorporation or founding date of Nuclotec Remedies Private Limited?
Nuclotec Remedies Private Limited was incorporated on 03 Jul 1995.
What is authorized share capital and paid-up capital of Nuclotec Remedies Private Limited?
The authorized share capital of Nuclotec Remedies Private Limited is ₹ 7.50 Cr and paid-up capital is ₹ 7.00 Cr.
Who are the current board members & directors of Nuclotec Remedies Private Limited?
Currently 2 directors are associated with Nuclotec Remedies Private Limited.
- Arun Anand
- Kanika Anand
What is the registered address of Nuclotec Remedies Private Limited?
As per Ministry of Corporate Affairs (Mca), the registered address of Nuclotec Remedies Private Limited is Office No-202 Iind Floor Vikramaditya Tower, Alaknanda Market India, Kalkaji, Delhi, 110019.
What is the corporate identification number (CIN) and company number of Nuclotec Remedies Private Limited?
The corporate identification number (CIN) of Nuclotec Remedies Private Limited is U74899DL1995PTC070408 and the company number is 070408 as per Ministry of Corporate Affairs (MCA).
What is the official website of Nuclotec Remedies Private Limited?
The Official website of Nuclotec Remedies Private Limited is https://www.nuclotec.com
What has been the recent revenue trend for Nuclotec Remedies Private Limited?
According to the financial reports for the fiscal year 2024, the revenue trend for Nuclotec Remedies Private Limited has risen by 13.09%.
How many employees does Nuclotec Remedies Private Limited currently have?
As Per 2024 financial reports, 110 employees are currently employed by Nuclotec Remedies Private Limited.
What change has been observed in the net worth of Nuclotec Remedies Private Limited, and by what percentage?
The financial reports for the fiscal year 2024 indicates that The net worth of Nuclotec Remedies Private Limited has experienced an downturn of -776.66%.
What are the total open charges for Nuclotec Remedies Private Limited?
As per the financial statements for fiscal Year 2024, The total open charges for Nuclotec Remedies Private Limited amount to ₹ 5.29 Cr.
When was the last Balance Sheet of Nuclotec Remedies Private Limited filed with the ROC?
The most recent Balance Sheet for Nuclotec Remedies Private Limited was filed with the ROC on 31 Mar 2024.
Unlock Business Insights – Explore Instantly!
Search company & director profiles for free and gain access to critical business data.
- 3.1M+ Companies
- 15M+ Legal Cases
- 525K+ Credit Ratings
- 5.8M+ Directors & KMP
- 750K+ Regulatory Alerts
- 1.1M+ Companies' Financial Records